Breaking News Instant updates and real-time market news.

C

Citi

$68.79

1.08 (1.60%)

, AIZ

Assurant

$94.04

0.7 (0.75%)

04:55
09/13/17
09/13
04:55
09/13/17
04:55

Barclays to hold a conference

Global Financial Services Conference is being held in New York on September 11-13.

C

Citi

$68.79

1.08 (1.60%)

AIZ

Assurant

$94.04

0.7 (0.75%)

NAVI

Navient

$14.42

0.29 (2.05%)

SPGI

S&P Global

$153.60

0.83 (0.54%)

SNV

Synovus

$43.15

0.58 (1.36%)

DBD

Diebold

$21.15

0.85 (4.19%)

PFSI

PennyMac Financial

MTB

M&T Bank

$149.02

2.5 (1.71%)

USB

U.S. Bancorp

$51.57

0.69 (1.36%)

RWT

Redwood Trust

$16.29

-0.13 (-0.79%)

ZION

Zions Bancorp

$43.33

0.6 (1.40%)

HBAN

Huntington Bancshares

$12.79

0.25 (1.99%)

ALL

Allstate

$91.87

0.64 (0.70%)

CME

CME Group

$130.06

1.26 (0.98%)

STT

State Street

$94.96

0.63 (0.67%)

RF

Regions Financial

$13.70

0.18 (1.33%)

GS

Goldman Sachs

$225.95

4.89 (2.21%)

WBS

Webster Financial

$48.03

1.17 (2.50%)

CMA

Comerica

$69.20

2.45 (3.67%)

RY

Royal Bank of Canada

$75.31

0.17 (0.23%)

WAL

Western Alliance

$47.67

1.07 (2.30%)

TD

Toronto-Dominion

$54.77

-0.04 (-0.07%)

JPM

JPMorgan

$90.89

1.1 (1.23%)

NYCB

New York Community Bancorp

$12.23

0.26 (2.17%)

KEY

KeyCorp

$17.46

0.43 (2.53%)

STI

SunTrust

$54.64

1.07 (2.00%)

BBT

BB&T

$44.79

0.11 (0.25%)

  • 13

    Sep

  • 14

    Sep

  • 18

    Sep

  • 18

    Sep

  • 19

    Sep

  • 12

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 23

    Oct

  • 08

    Nov

  • 09

    Nov

  • 17

    Jan

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

C Citi
$68.79

1.08 (1.60%)

07/31/17
07/31/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Facebook (FB) downgraded to Sell from Hold at Pivotal Research with analyst Brian Wieser saying the shares are not factoring in risks to the company's growth following their "remarkable run" this year. 2. Ulta Beauty (ULTA) downgraded to Perform from Outperform at Oppenheimer with analyst Rupesh Parikh saying softer commentary from L'Oreal on its earnings call, increasing promotional activity from the department store channel, and more difficult year-over-year comparisons "could now signal a potentially more challenging beauty backdrop going forward." 3. Hertz (HTZ) downgraded to Underweight from Equal Weight at Barclays with analyst Brian Johnson saying fundamentals may have bottomed, but the stock is ignoring the challenges ahead in the company's earnings recovery following the nearly 100% rally since June 21. 4. Citi (C) downgraded to Market Perform from Outperform at BMO Capital with analyst James Fotheringham citing valuation and lack of catalysts. 5. Visteon (VC) downgraded to Neutral from Buy at UBS with analyst Colin Langan saying the risk/reward is more balanced with the shares up 60% over the last year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/09/17
WELS
08/09/17
INITIATION
Target $265
WELS
Outperform
Goldman Sachs resumed with an Outperform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of Goldman Sachs (GS) with an Outperform rating and $265 price target. The analyst prefers Goldman over Morgan Stanley (MS), saying the bank has about "twice as fast" organic revenue growth for more than 20 years, and "much faster" earnings growth over 15 years. Mayo named Citi (C) his top pick among the Large-Cap banks.
09/11/17
SOCG
09/11/17
UPGRADE
SOCG
Hold
Citi upgraded to Hold from Sell at Societe Generale
08/09/17
WELS
08/09/17
INITIATION
Target $90
WELS
Outperform
Citi resumed at Outperform, added to Priority Stock List at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of Citi with an Outperform rating and $90 price target. The analyst calls Citi his top pick in Large-Cap U.S. Banks and added the shares to his firm's Priority Stock List. Mayo expects the stock to double in four-to-five years. He believes Citi should show the best improvement among large banks in both return on equity and cost of capital.
AIZ Assurant
$94.04

0.7 (0.75%)

01/09/17
BOFA
01/09/17
DOWNGRADE
Target $93
BOFA
Underperform
Assurant downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Seth Weiss downgraded Assurant to Underperform citing recent share strength and maintained its $93 price target.
10/20/16
BOFA
10/20/16
DOWNGRADE
BOFA
Neutral
Assurant downgraded to Neutral from Buy at BofA/Merrill
01/12/17
RHCO
01/12/17
NO CHANGE
RHCO
Assurant price target raised to $115 from $105 at SunTrust
SunTrust analyst Mark Hughes raised his price target on Assurant as he expects the company to benefit from improved smartphone metrics in 2017 versus 2016. He keeps a Buy rating on the shares.
10/20/16
BOFA
10/20/16
DOWNGRADE
Target $87
BOFA
Neutral
Assurant downgraded to Neutral on weak preliminary Q3 results at BofA/Merrill
BofA/Merrill downgraded Assurant to Neutral and lowered its price target to $87 from $96 saying the weaker preliminary Q3 results suggests a reduction in earnings power for the Solutions segment.
NAVI Navient
$14.42

0.29 (2.05%)

09/05/17
COMP
09/05/17
UPGRADE
Target $16.5
COMP
Buy
Navient upgraded to Buy from Neutral at Compass Point
Compass Point upgraded Navient to Buy from Neutral with a $16.50 price target. Analyst Michael Tarkan believes the regulatory environment for student lenders/servicers will become more benign over the next few years following the Department of Educations announcement that it intends to end two information sharing agreements with the CFPB related to oversight of federal loans. The analyst expects Navient to be a beneficiary of reduced regulation and said the recent pullback in shares provides an favorable entry point.
09/05/17
COMP
09/05/17
UPGRADE
COMP
Buy
Navient upgraded to Buy from Neutral at Compass Point
01/30/17
WEDB
01/30/17
INITIATION
Target $16.5
WEDB
Neutral
Navient initiated with a Neutral at Wedbush
Wedbush initiated Navient with a Neutral and a $16.50 price target.
09/08/17
FBCO
09/08/17
UPGRADE
Target $16.5
FBCO
Outperform
Navient upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Moshe Orenbuch upgraded Navient to Outperform saying shares are "too cheap" after a 20% selloff year-to-date and maintained a $16.50 price target. The analyst said has several positives including strong cash flows should lead to substantial repurchases, government loan margin supported by improved 3/1 month libor spread, reduced regulatory risk, and a call option on tax reform.
SPGI S&P Global
$153.60

0.83 (0.54%)

05/01/17
FBCO
05/01/17
NO CHANGE
Target $155
FBCO
Outperform
S&P Global price target raised to $155 from $131 at Credit Suisse
Credit Suisse analyst Anjaneya Singh raised his price target for S&P Global to $155 from $131 after the company exceeded expectations for the quarter, driven by strength across its Ratings business segment and by strong contributions from other segments. While there may be questions on the momentum of issuance for the remainder of 2017, the analyst believes the potential risks are offset by opportunities for S&P Global PGI in its other businesses, on both top line and margins. He reiterates an Outperform rating on the shares.
07/28/17
UBSW
07/28/17
NO CHANGE
Target $173
UBSW
Buy
S&P Global price target raised to $173 from $154 at UBS
UBS analyst Alex Kramm raised his price target on S&P Global to $173 from $154 following strong Q2 results. The analyst noted its raised guidance for both organic revenue and earnings and he sees the company further unlocking revenue and margin opportunities. Kramm reiterated his Buy rating on S&P Global shares.
04/26/17
UBSW
04/26/17
NO CHANGE
Target $154
UBSW
Buy
S&P Global price target raised to $154 from $140 at UBS
UBS analyst Alex Kramm raised his price target on S&P Global to $154 from $140 following Q1 results. The analyst believes the company's raised guidance is its first after a Q1 release, noting that it cited solid organic growth and margin expansion across all segments. Kramm believes investors are not fully appreciating the value of the company's non-rating segments, which he believes should continue to deliver this year. Kramm reiterated his Outperform rating on S&P Global shares.
04/17/17
RAJA
04/17/17
UPGRADE
Target $143
RAJA
Outperform
S&P Global upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Patrick O'Shaughnessy upgraded S&P Global and established a $143 price target. The analyst views valuation as reasonable and expects S&P to generate consistent double-digit earnings growth due to steady revenue growth, margin expansion, and healthy capital returns.
SNV Synovus
$43.15

0.58 (1.36%)

07/17/17
RBCM
07/17/17
INITIATION
RBCM
Outperform
Synovus initiated with an Outperform at RBC Capital
RBC Capital analyst Jake Civiello expects Synovus to benefit from accelerating topline growth into 2018, increased focus on loan profitability maximization and improving operating efficiency. Target $51.
03/30/17
SPHN
03/30/17
NO CHANGE
Target $64
SPHN
Overweight
TSYS could see 'a small benefit' from Cabela's sale, says Stephens
Stephens analyst Brett Huff thinks TSYS (TSS) could see "a small benefit" from the sale of Cabela's (CAB). After being delayed by regulatory approvals, The Wall Street Journal is reporting that Bass Pro would buy the retail ops, Synovus (SNV) would buy bank/co-branded credit card portfolio, and in turn selling the portfolio to Capital One (COF), he notes. The analyst points out that TSYS is Capital One's card issuing processor, and says he thinks the about 2M active cards would move to TSYS' platform. Huff reiterates an Overweight rating and $64 price target on TSYS's shares.
05/11/17
BOFA
05/11/17
UPGRADE
BOFA
Buy
Synovus upgraded to Buy from Neutral at BofA/Merrill
05/11/17
05/11/17
UPGRADE

Buy
Synovus upgraded to Buy at BofA/Merrill
As previously reported, BofA/Merrill upgraded Synovus to Buy from Neutral and raised its price target to $50. The firm views risk/reward as attractive given outlook for above average earnings growth and views it as an attractive M&A target for a larger bank given the attractiveness of its Southeast footprint.
DBD Diebold
$21.15

0.85 (4.19%)

07/12/17
FBCO
07/12/17
NO CHANGE
Target $26
FBCO
Outperform
Diebold upside could be 'substantial,' says Credit Suisse
Following the guidance reduction, Credit Suisse analyst Paul Condra believes the selloff was "a bit overdone" and expects the stock could regain some lost ground in the near-term. However, the move closer to $30 is likely to be mid to longer-term, he contends. Condra reiterates an Outperform rating and $26 price target on the shares.
07/05/17
JPMS
07/05/17
NO CHANGE
JPMS
Overweight
NCR should be bought on today's weakness, says JPMorgan
JPMorgan analyst Paul Coster recommends using the weakness in shares of NCR Corp. (NCR) following Diebold's (DBD) preannouncement as a buying opportunity. After touching base with NCR, the analyst thinks the issues at Diebold are company specific and that NCR remains on track to meet expectations. While more cautious Diebold's near-term prospects, Coster believes today's 20% selloff "seems excessive." He thinks the company's execution issues probably get resolved by year-end. The analyst keeps Overweight ratings on both stocks.
07/10/17
JPMS
07/10/17
NO CHANGE
JPMS
JPMorgan says buy NCR and Diebold on recent pullback
JPMorgan analyst Paul Coster recommends buying both NCR Corp. (NCR) and Diebold (DBD) on the recent weakness caused by Diebold's negative preannouncement last week. After speaking to both managements, the analyst concludes that the companies are experiencing "largely uninterrupted" demand for ATMs, retail self-checkout terminals and for software-based omni-channel solutions. The analyst prefers NCR to Diebold and keeps Overweight ratings on both names.
08/08/17
JPMS
08/08/17
DOWNGRADE
Target $31
JPMS
Neutral
Diebold downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Paul Coster downgraded Diebold (DBN) to Neutral citing a lack of near-term catalysts and valuation following the company's Q2 results. The analyst prefers Overweight-rated peer NCR Corp. (NCR) at current trading multiples. He has a $31 price target for Diebold shares.
PFSI PennyMac Financial

02/08/17
JMPS
02/08/17
DOWNGRADE
JMPS
Market Perform
PennyMac downgraded to Market Perform from Outperform at JMP Securities
JMP Securities analyst Trevor Cranston downgraded PennyMac Financial to Market Perform saying shares have surpassed his $18 price target and trading at a 52-week high despite headwinds from a projected 20% smaller mortgage origination market in 2017 and tighter gain on sale margins due to increased competition.
02/06/17
COMP
02/06/17
UPGRADE
COMP
Buy
PennyMac upgraded earlier to Buy from Neutral at Compass Point
04/11/17
04/11/17
NO CHANGE

PennyMac Financial strength attributed to positive mention at Navelier
PennyMac Financial Services shares are up 45c, or 2.8%, to $16.55 in morning trading.
12/15/16
BOFA
12/15/16
DOWNGRADE
Target $17.5
BOFA
Underperform
PennyMac Financial downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Kenneth Bruce downgraded PennyMac Financial to Underperform and lowered its price target to $17.50 from $18.50. The analyst sees risk to mortgage related stocks in a rising rate environment with increased volatility as rate sensitive assets erode book value and a flatter yield cure pressures earnings. The firm believes deflation has peaked, and the expected unwind will result in sector rotation out of bonds.
MTB M&T Bank
$149.02

2.5 (1.71%)

07/11/17
JEFF
07/11/17
UPGRADE
Target $186
JEFF
Buy
M&T Bank upgraded to Buy from Hold at Jefferies
Jefferies analyst Ken Usdin upgraded M&T Bank to Buy and raised his price target for the shares to $186 from $174. The analyst expects a "beat-and-raise" Q2 to bring positive out-year earnings revisions. He sees a turn in fee growth and a better cost outlook for the bank.
08/09/17
WELS
08/09/17
INITIATION
Target $170
WELS
Market Perform
M&T Bank resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of M&T Bank with a Market Perform rating and $170 price target.
01/11/17
UBSW
01/11/17
DOWNGRADE
Target $150
UBSW
Sell
M&T Bank downgraded to Sell from Neutral at UBS
UBS analyst David Eads downgraded M&T Bank to Sell saying the valuation is full at current levels. The analyst recommends caution in the U.S. Small and Mid-cap Commercial Banks space and raised his price target for the shares to $150 from $145.
08/04/17
MACQ
08/04/17
DOWNGRADE
Target $152
MACQ
Underperform
M&T Bank downgraded to Underperform from Neutral at Macquarie
Macquarie analyst David Konrad downgraded M&T Bank to Underperform with a $152 price target saying valuation is stretched, combined with a deceleration of the balance sheet and less potential pricing leverage with Hudson City CDs will likely pressure consensus estimates.
USB U.S. Bancorp
$51.57

0.69 (1.36%)

06/09/17
RBCM
06/09/17
NO CHANGE
RBCM
House financial reform bill unlikely to advance in Senate, says RBC Capital
RBC Capital analyst Gerard Cassidy says that the financial regulation reform bill passed yesterday by the House would help the banking sector but probably won;t be passed by the Senate. Large publicly traded banks include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
07/20/17
ARGS
07/20/17
UPGRADE
ARGS
Buy
U.S. Bancorp upgraded on results at Argus
As noted earlier, Argus upgraded U.S. Bancorp to Buy from Hold. Analyst Stephen Biggar upgraded the stock after the company reported its Q2 results. As reasons for the upgrade, he cited its "above-peer-average return on equity, return on assets and efficiency metrics, as well as earnings consistency," Target $57.
08/09/17
WELS
08/09/17
INITIATION
Target $56
WELS
Market Perform
U.S. Bancorp resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of U.S. Bancorp with a Market Perform rating and $56 price target.
07/20/17
ARGS
07/20/17
UPGRADE
ARGS
Buy
U.S. Bancorp upgraded to Buy from Hold at Argus
RWT Redwood Trust
$16.29

-0.13 (-0.79%)

ZION Zions Bancorp
$43.33

0.6 (1.40%)

08/28/17
RHCO
08/28/17
NO CHANGE
RHCO
Texas bank weakness creates buying opportunity, says SunTrust
SunTrust analyst Jennifer Demba predicts that the flooding in Texas will negatively impact the stocks of banks based in the state. She thinks that the "probable" weakness of the following bank stocks will create buying opportunities: Zions Bancorp (ZION), Cullen/Frost (CFR), Prosperity Bancshares (PB), and Texas Capital (TCBI).
09/08/17
BARD
09/08/17
UPGRADE
BARD
Neutral
Zions Bancorp upgraded to Neutral from Underperform at Baird
08/16/17
BOFA
08/16/17
UPGRADE
Target $52
BOFA
Buy
Zions Bancorp upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Erika Najarian upgraded Zions Bancorp to Buy and increased its price target to $52 from $50 following an "upbeat" management meeting. The analyst believes investors are discounting two catalysts for earnings upside including benefits from regulatory reform for regionals and continued improvement in expense management. Additionally, he expects large short interest in shares to be a tailwind.
08/16/17
08/16/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: Home Depot (HD) upgraded to Outperform from Market Perform at Raymond James with analyst Budd Bugatch saying the company continues to execute at a "world-class level." 2. Mylan (MYL) upgraded to Buy from Neutral at Citi with analyst Liav Abraham saying the company is best positioned to execute in a challenging operating environment for generics. 3. Biogen (BIIB) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Terence Flynn saying he continues to see optionality Aducanumab, its lead pipeline Alzheimer's drug. 4. Zions Bancorp (ZION) upgraded to Buy from Neutral at BofA/Merrill with analyst Erika Najarian saying she believes investors are discounting two catalysts for earnings upside including benefits from regulatory reform for regionals and continued improvement in expense management. 5. Paychex (PAYX) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Danyal Hussain saying expectations adequately capture downside risks and the valuation premium is the lowest since 2008. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HBAN Huntington Bancshares
$12.79

0.25 (1.99%)

08/10/17
PIPR
08/10/17
UPGRADE
PIPR
Overweight
Huntington Bancshares upgraded to Overweight from Neutral at Piper Jaffray
08/31/17
JMPS
08/31/17
INITIATION
JMPS
Outperform
Huntington Bancshares initiated with an Outperform at JMP Securities
JMP Securities analyst Emlen Harmon started coverage of Huntington Bancshares with a $15 price target and an Outperform rating. Analyst Emlen Harmon says that the company is "well-positioned through the cycle" due to its conservative approach, while its multiple should rise in the near-term. The analyst thinks that the company should benefit from the strength of its auto lending business and from tis First Merit acquisition.
08/11/17
PIPR
08/11/17
UPGRADE
Target $15
PIPR
Overweight
Huntington Bancshares upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Kevin Barker upgraded Huntington Bancshares to Overweight and raised his price target for the shares to $15 from $14. The "disappointing" expense guidance has lowered expectations while Huntington should grow earnings faster than any regional bank peer in FY18 and FY19, the analyst contends.
08/11/17
08/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) upgraded to Overweight from Equal Weight at Stephens with analyst Ben Bienvenu saying that the company's multi-year investments have led to a better in-store experience, which he sees continuing to drive momentum. 2. Kohl's (KSS) upgraded to Neutral from Underperform at Credit Suisse. 3. Huntington Bancshares (HBAN) upgraded to Overweight from Neutral at Piper Jaffray with analyst Kevin Barker saying the "disappointing" expense guidance has lowered expectations while Huntington should grow earnings faster than any regional bank peer in fiscal 2018 and fiscal 2019. 4. Axalta Coating (AXTA) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the 16% pullback over the past three weeks has created an investment opportunity. 5. Perrigo (PRGO) upgraded to Neutral from Sell at Goldman Sachs with analyst Jami Rubin saying the quarterly results may mark the beginning of inflection towards stabilization in the Rx business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ALL Allstate
$91.87

0.64 (0.70%)

09/11/17
BUCK
09/11/17
INITIATION
Target $74
BUCK
Underperform
Allstate initiated with an Underperform at Buckingham
Buckingham analyst Amit Kumar initiated Allstate with an Underperform and a $74 price target.
09/01/17
MSCO
09/01/17
NO CHANGE
MSCO
Harvey loss uncertainty to remain overhang on P&C stocks, says Morgan Stanley
Morgan Stanley analyst Kai Pan currently estimates $15B-$40B in total insured losses from Harvey, including $5B-$15B in National Flood Insurance Program, or NFIP, claims. P&C stocks the firm covers have declined 2.7% on average since August 23, noted Pan, who thinks the uncertainty of losses will remain a near-term overhang on the group. If the ultimate losses are contained within quarterly earnings, the stocks could rebound, added Pan. Stocks in the P&C insurance space include Allstate (ALL), Travelers (TRV), Progressive (PGR), Chubb (CB), AIG (AIG).
09/11/17
MKMP
09/11/17
NO CHANGE
MKMP
Arch Capital, AXIS Capital named as favorable insurance names at MKM Partners
MKM Partners analyst Harry Fong says that Arch Capital (ACGL) "could have the best prospects" in the wake of the recent hurricanes. The analyst says that the company's property catastrophe exposure has dropped significantly, and he reports that the company has estimated its "probable maximum loss in the tri-county area of Florida to be $370M for a 1-in-250 year kind of event," representing "less than 4% of its equity." The analyst adds that the company's on-shore marine business could suffer losses. However, he keeps a $120 price target and a Buy rating on the stock. Fong adds that AXIS has also reduced its property exposure in recent years. However, he adds that Novea which AXIS is looking to purchase could have exposure to Florida. Nonetheless, he thinks that AXIS' risk/reward ratio is positive and he keeps an $80 price target and a Buy rating on the shares. Fong adds that he expects insurers to benefit from significant rate increases going forward that will enable them to erase their hurricane losses in a short time. . He keeps Buy ratings on Allstate (ALL) and Progressive (PGR)
09/11/17
JPMS
09/11/17
NO CHANGE
JPMS
Irma losses could be lower than expected, says JPMorgan
JPMorgan analyst Sarah DeWitt believes losses from Hurricane Irma could be at the lower end of the $20B-$60B expected range since the storm weakened faster than expected. The analyst estimates the impact to book values for the companies she covers should be a "manageable" 1%-2%. Among the property casualty insurers, the analyst views Validus (VR), Everest Re (RE) and XL Group (XL) as the most oversold. She lists those three along with RenaissanceRe (RNR), Travelers (TRV), Arch Capital (ACGL), Chubb (CB), Allstate (ALL) and Progressive (PGR) as the P&C insurers with the most exposure to U.S. hurricanes.
CME CME Group
$130.06

1.26 (0.98%)

09/08/17
LEHM
09/08/17
INITIATION
Target $139
LEHM
Overweight
CME Group initiated with an Overweight at Barclays
Barclays analyst Jeremy Campbell started CME Group with an Overweight rating and $139 price target. The analyst initiated U.S. Brokers, Asset Managers & Exchanges with a Neutral industry view.
08/16/17
DBAB
08/16/17
NO CHANGE
Target $135
DBAB
Buy
CME Group reiterated as top exchange pick at Deutsche Bank
Deutsche Bank analyst Brian Bedell reiterates CME Group as his top exchange pick after hosting investor meetings with management. The company's "multiple organic growth opportunities" make the stock much more than just a play on interest rates or macro volatility, Bedell tells investors in a research note. He keeps a Buy rating on CME with a $135 price target.
07/12/17
SBSH
07/12/17
DOWNGRADE
Target $16
SBSH
Sell
Virtu Financial downgraded to Sell from Neutral at Citi
Citi analyst Ben Herbert downgraded Virtu Financial (VIRT) to Sell and lowered his price target for the shares to $16 from $17 after taking over lead coverage from William Katz. The analyst has concerns over peak penetration, dividend pressure and the likely reduction of consensus estimates. He recommends a pair trade of long CME Group (CME), short Virtu.
07/12/17
SBSH
07/12/17
INITIATION
Target $140
SBSH
Buy
CME Group initiated with a Buy at Citi
Citi analyst Ben Herbert started CME Group with a Buy rating and $140 price target. "Deep" franchises in Energy, Fed Fund Futures and Treasury Futures and Options make CME the best positioned U.S. exchange, the analyst contends.
STT State Street
$94.96

0.63 (0.67%)

06/28/17
GSCO
06/28/17
UPGRADE
Target $100
GSCO
Conviction Buy
State Street upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman analyst Alexander Blostein added State Street to the Conviction Buy List and increased its price target to $100 from $92 saying pre-tax margin targets look conservative, providing confidence in above consensus estimates. The analyst estimates fee growth grew 4%+ quarter-over-quarter in Q2 due to a favorable fee mix shift amid non-US equities outperformance and flows accelerated into the company's higher-fee ETFs.
08/09/17
WELS
08/09/17
INITIATION
Target $115
WELS
Outperform
State Street initiated with an Outperform at Wells Fargo
Wells Fargo analyst Mike Mayo started State Street with an Outperform rating and $115 price target.
07/27/17
EVER
07/27/17
UPGRADE
Target $95
EVER
In Line
State Street upgraded to In Line from Underperform at Evercore ISI
Evercore ISI analyst Glenn Schorr upgraded State Street to In Line with a $95 price target following the strong Q2 report citing improved execution and expects share to perform inline with the group despite continued fee pressure and competitive threats.
07/27/17
07/27/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Boeing (BA) was upgraded to Outperform from Neutral at Credit Suisse, to Buy from Neutral at BofA/Merrill, to Neutral from Sell at Goldman Sachs, and to Sector Perform from Underperform at RBC Capital. 2. State Street (STT) upgraded to In Line from Underperform at Evercore ISI with analyst Glenn Schorr citing improved execution and expects share to perform inline with the group despite continued fee pressure and competitive threats. 3. Vermilion Energy (VET) upgraded to Outperform from Sector Perform at RBC Capital. 4. DDR Corp. (DDR) upgraded to Buy from Hold at Deutsche Bank with analyst Vin Chao saying new management's progress towards balance sheet and disposition plans has much improved FFO visibility. 5. Rockwell Automation (ROK) upgraded to Neutral from Underweight at JPMorgan with analyst C. Stephen Tusa saying the company reported another quarter of "strong organic growth and solid fundamentals." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
RF Regions Financial
$13.70

0.18 (1.33%)

07/26/17
07/26/17
UPGRADE

Regions Financial upgraded to Strong Buy from Outperform at Vining Sparks
Vining Sparks analyst Marty Mosby upgraded Regions Financial to Strong Buy and raised his price target for the shares to $17.50 from $16.
07/26/17
BOFA
07/26/17
NO CHANGE
Target $17
BOFA
Buy
Regions Financial added to US 1 List at BofA/Merrill
BofA/Merrill analyst Erika Najarian added Regions Financial to the US 1 List and reiterated its Buy rating and $17 price target. Najarian continues to view Regions as undervalued based on capital return potential, core deposit strength, and management's focus on efficiency improvements in 2018.
06/29/17
WEDB
06/29/17
NO CHANGE
WEDB
Regions Financial 'the big winner' of CCAR, says Wedbush
Wedbush says that Regions was "the big winner" of CCAR. The firm notes that the bank had "a total capital return forecast of 158% of net income well above" the average of 97% among regional banks it covers. However, Wedbush keeps a Neutral rating on the stock.
08/09/17
WELS
08/09/17
INITIATION
Target $16
WELS
Market Perform
Regions Financial resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of Regions Financial with a Market Perform rating and $16 price target.
GS Goldman Sachs
$225.95

4.89 (2.21%)

09/12/17
KBWI
09/12/17
NO CHANGE
KBWI
Market Perform
Keefe Bruyette 'somewhat skeptical' of Goldman Sachs revenue targets
Keefe Bruyette analyst Brian Kleinhanzl noted that Goldman Sachs co-COO Harvey Schwartz identified $5B in revenue opportunities that the company sees over the next 3 years, though he is "somewhat skeptical" of the bank's ability to hit these targets given that its strategy requires penetrating new markets or segments outside of its traditional strengths. The analyst, who thinks Goldman remains a "show-me stock," keeps a Market Perform rating on the shares.
07/24/17
07/24/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Goldman Sachs (GS) downgraded to Neutral from Buy at UBS with analyst Brennan Hawken saying the market seems to be pricing in an inflection in Goldman's trading revenue despite the recent weakness, suggesting a recovery is needed to justify 2018 consensus estimates. 2. Constellation Brands (STZ) downgraded to Neutral from Conviction Buy at Goldman Sachs. 3. Boston Beer (SAM) downgraded to Sell from Neutral at Goldman Sachs with analyst Judy Hong saying she sees further downside risk from weaker volumes and believes 2018 will be another year of volume decline and limited margin offset. 4. athenahealth (ATHN) downgraded to Underweight from Equal-Weight at First Analysis with analyst Frank Sparacino saying the valuation at current share levels is ahead of the underlying fundamentals in the short term. 5. PPG (PPG) was downgraded to Hold from Buy at SunTrust and to Neutral from Buy at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/11/17
HSBC
08/11/17
DOWNGRADE
HSBC
Hold
Goldman Sachs downgraded to Hold from Buy at HSBC
WBS Webster Financial
$48.03

1.17 (2.50%)

06/28/17
WEDB
06/28/17
INITIATION
WEDB
Outperform
Webster Financial initiated with an Outperform at Wedbush
Wedbush analyst David J. Chiaverini started coverage of Webster Financial with a $60 price target and an Outperform rating. The analyst expects the company's HSA subsidiary to generate "extraordinary growth..for years to come."
11/14/16
WELS
11/14/16
DOWNGRADE
WELS
Market Perform
Webster Financial downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jared Shaw downgraded Webster Financial to Market Perform citing valuation following the recent rally of the shares. The analyst raised his price target range for the shares to $44-$46 from $40-$45.
11/16/16
PIPR
11/16/16
DOWNGRADE
Target $37.5
PIPR
Underweight
Webster Financial downgraded to Underweight from Neutral at Piper Jaffray
Piper Jaffray analyst Matthew Breese downgraded Webster Financial to Underweight saying it is time to take profits following the recent rally in the shares. The analyst keeps a $37.50 price target for the shares.
11/08/16
DBAB
11/08/16
DOWNGRADE
DBAB
Hold
Webster Financial downgraded to Hold from Buy at Deutsche Bank
CMA Comerica
$69.20

2.45 (3.67%)

09/12/17
PIPR
09/12/17
UPGRADE
PIPR
Overweight
Comerica upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Brett Rabatin upgraded Comerica to Overweight and raised his price target for the shares to $80 from $76 saying the bank's mid-quarter update is better than expected. The analyst believes the recent pullback in shares creates an attractive entry point.
09/12/17
09/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comerica (CMA) upgraded to Overweight from Neutral at Piper Jaffray with analyst Brett Rabatin saying the bank's mid-quarter update is better than expected. 2. Alcoa (AA) upgraded to Buy from Hold at Deutsche Bank with analyst Jorge Beristain basing the upgrade on the firm's commodity team raising its 2018 aluminum price forecast by 12% to $2,072 per ton. 3. Kroger (KR) upgraded to Buy from Hold at Pivotal Research with analyst Ajay Jain saying continued weakness in investor sentiment following Kroger's latest results presents a near-term buying opportunity. 4. Comcast (CMCSA) upgraded to Buy from Neutral at MoffettNathanson with analyst Craig Moffett saying Comcast shares cheap following management comments on third quarter subscriber loses and the resulting stock selloff is overdone. 5. Inovalon (INOV) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Ricky Goldwasser saying that the company's presentation at the firm's healthcare conference provided a line of sight to organic earnings acceleration in the second half of the year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/09/17
06/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Zynga (ZNGA) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Brian Nowak saying the company's in-game innovation, starting with Poker, is resulting in higher engagement and monetization. 2. Citi (C) upgraded to Neutral from Sell at UBS with analyst Saul Martinez saying he sees an improved risk/reward at current share levels. Global growth "looks resilient," protectionist policies have not emerged, and the path forward for structural reforms in the U.S. "is not as clear." 3. Comerica (CMA) upgraded to Outperform from Market Perform at FBR Capital. 4. Camping World (CWH) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying he expects growth to continue despite late-cycle concerns. 5. Humana (HUM) upgraded to Buy from Hold at Argus with analyst David Toung saying he is upbeat about its growth outlook following the termination of its merger deal with Aetna (AET). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/09/17
WELS
08/09/17
INITIATION
Target $73
WELS
Market Perform
Comerica resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of Comerica with a Market Perform rating and $73 price target.
RY Royal Bank of Canada
$75.31

0.17 (0.23%)

04/03/17
TDSI
04/03/17
DOWNGRADE
TDSI
Hold
Royal Bank of Canada downgraded to Hold from Buy at TD Securities
TD Securities analyst Mario Mendonca downgraded Royal Bank of Canada to Hold primarily due to valuation and relative outperformance.
12/01/16
RAFF
12/01/16
DOWNGRADE
RAFF
Hold
Royal Bank of Canada downgraded to Hold from Buy at Rafferty Capital
02/27/17
KBWI
02/27/17
UPGRADE
KBWI
Market Perform
Royal Bank of Canada upgraded to Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Klock upgraded Royal Bank of Canada to Market Perform from Underperform with an increased price target of C$99.
08/21/17
HOWW
08/21/17
DOWNGRADE
HOWW
Sector Perform
Royal Bank of Canada downgraded to Sector Perform at Scotia Howard Weil
WAL Western Alliance
$47.67

1.07 (2.30%)

08/18/17
RHCO
08/18/17
INITIATION
Target $59
RHCO
Buy
Western Alliance initiated with a Buy at SunTrust
SunTrust analyst Michael Young started Western Alliance with a Buy rating and $59 price target. The company is one of the "premier growth banks" in the country with over 20% growth in loans and earnings over the past three years, the analyst contends.
02/14/17
LEHM
02/14/17
INITIATION
Target $58
LEHM
Overweight
Western Alliance initiated with an Overweight at Barclays
Barclays analyst Matthew Keating started Western Alliance Bancorporation with an Overweight rating and $58 price target. Loan growth and net interest margin expansion amid rising rates should drive above-consensus earnings, the analyst contends.
09/27/16
JEFF
09/27/16
NO CHANGE
Target $42
JEFF
Buy
Western Alliance has capacity to start dividend, says Jefferies
Jefferies analyst Casey Haire says Western Alliance's "strong" capital ratio and organic capital generation give it the capacity to implement a dividend. A 10%-20% dividend payout ratio would provide some yield and still enable Western "to build upon already strong capital ratios," Haire tells investors in a research note. The analyst keeps a Buy rating on the shares with a $42 price target.
11/10/16
RBCM
11/10/16
INITIATION
RBCM
Outperform
Western Alliance coverage assumed with an Outperform at RBC Capital
Target to $46 from $42.
TD Toronto-Dominion
$54.77

-0.04 (-0.07%)

09/01/17
NATB
09/01/17
UPGRADE
NATB
Outperform
Toronto-Dominion upgraded to Outperform from Sector Perform at National Bank
09/01/17
BOFA
09/01/17
NO CHANGE
BOFA
Buy
Toronto-Dominion still not to late to buy, says BofA/Merrill
BofA/Merrill analyst Ebrahim Poonawala said Toronto-Dominion reported Q3 results that beat his expectations on the back of stronger revenue growth. The analyst expects outperformance to continue for Buy rated Toronto-Dominion and said it is not too late to buy shares.
08/21/17
HOWW
08/21/17
UPGRADE
HOWW
Outperform
Toronto-Dominion upgraded to Outperform at Scotia Howard Weil
09/01/17
09/01/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Palo Alto Networks (PANW) was upgraded to Overweight from Neutral at JPMorgan and to Overweight from Equal-Weight at First Analysis. 2. Gap (GPS) upgraded to Neutral from Sell at Citi, with analyst Paul Lejuez saying concerns of a slowdown at Old Navy appear more priced in at current valuation levels. He raised his price target for the shares to $24 from $22. 3. Gerdau (GGB) upgraded to Overweight from Neutral at JPMorgan with analyst Rodolfo Angele saying the company's business environment has improved. 4. Owens & Minor (OMI) upgraded to Neutral from Underperform at Baird with analyst Eric Coldwell citing its relative underperformance. 5. Toronto-Dominion (TD) upgraded to Outperform from Sector Perform at National Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
JPM JPMorgan
$90.89

1.1 (1.23%)

07/11/17
BARD
07/11/17
NO CHANGE
BARD
Big bank set-up not great, would sell into extended rally, says Baird
Baird analyst David George does not see a great set-up for money-center banks heading into Q2 earnings. He said the trade looks crowded and he would be a seller into an extended rally. George said the risk/reward is less attractive following the sector's most recent rally as economic growth remains muted and the pace of NIM expansion may slow. George believes the biggest potential catalyst would be a gradual steepening of the yield curve and pick-up on loan growth.
07/06/17
07/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nike (NKE) initiated with an Outperform at Raymond James. 2. JPMorgan (JPM) initiated with a Neutral at Goldman Sachs. 3. At Home Group (HOME) initiated with a Buy at SunTrust. 4. Logitech (LOGI) initiated with a Buy at Citi. 5. Medtronic (MDT) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/09/17
WELS
08/09/17
INITIATION
Target $110
WELS
Outperform
JPMorgan resumed with an Outperform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage JPMorgan with an Outperform rating and $110 price target.
07/06/17
GSCO
07/06/17
INITIATION
Target $93
GSCO
Neutral
JPMorgan initiated with a Neutral at Goldman Sachs
Goldman analyst Richard Ramsden resumed coverage on JPMorgan with a Neutral and a $93 price target saying it is a best-in-class franchise with a premium multiple.
NYCB New York Community Bancorp
$12.23

0.26 (2.17%)

12/21/16
FBRC
12/21/16
DOWNGRADE
Target $15
FBRC
Underperform
New York Community Bancorp downgraded to Underperform at FBR Capital
FBR Capital analyst Bob Ramsey downgraded New York Community Bancorp (NYCB) to Underperform from Market Perform following the termination of the company's planned merger with Astoria Financial (AF). The analyst assumed 10% earnings accretion from the deal. He lowered his price target for New York Community Bancorp shares to $15 from $17.
04/05/17
SPHN
04/05/17
INITIATION
SPHN
Equal Weight
New York Community Bancorp initiated with an Equal Weight at Stephens
Stephens analyst Erik Zwick initiated New York Community Bancorp with an Equal Weight rating.
04/11/17
MSCO
04/11/17
NO CHANGE
Target $14.5
MSCO
Equal Weight
New York Community Bancorp could surprise to upside,says Morgan Stanley
Morgan Stanley analyst Ken Zerbe said New York Community Bancorp has underperformed peers and the market is giving little credit for potential positive surprises. Zerbe said shares could surprise to the upside from potential catalysts that include another large acquisitions, accelerated balance sheet growth, and reduced liability sensitivity. The analyst rates shares an Equal Weight with a $14.50 price target.
12/21/16
12/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Hold from Buy at Stifel with analyst Astrachan citing "recent negative FX movement, moderate anticipated input cost inflation, and continued heightened geopolitical uncertainty." 2. JetBlue (JBLU) downgraded to Market Perform from Outperform at Raymond James with analyst Savanthi Syth saying shares will be range bound near-term due to RASM pressures from capacity growth new market expansion, and increased cost inflation. 3. Barrick Gold (ABX) downgraded to Hold from Buy at TD Securities analyst Greg Barnes saying shares have significantly outperformed in 2016 and sees fewer company-specific catalysts in 2017. 4. New York Community Bancorp (NYCB) and Astoria Financial (AF) were downgraded to Underperform at FBR Capital. 5. Goldman Sachs (GS) and U.S. Bancorp (USB) were downgraded to Neutral from Overweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
KEY KeyCorp
$17.46

0.43 (2.53%)

07/20/17
NOMU
07/20/17
NO CHANGE
Target $23
NOMU
Buy
KeyCorp should be accumulated on weakness, says Nomura Instinet
Nomura Instinet analyst Bill Carcache recommends accumulating shares of KeyCorp on today's post-earnings weakness. The selloff on the in-line Q2 results is overdone, Carcache told investors earlier in a research note. He reiterated a Buy rating on the shares with a $23 price target.
07/11/17
07/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. KeyCorp (KEY) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Klock saying he sees valuation expansion as the market further appreciates the company's leading return on assets and stable earnings. 2. Exxon Mobil (XOM) and Imperial Oil (IMO) were upgraded to Overweight from Equal Weight at Barclays. 3. Westar Energy (WR) was upgraded to Outperform from In Line at Evercore ISI and to Overweight from Neutral at JPMorgan. 4. STMicroelectronics (STM) upgraded to Overweight from Neutral at JPMorgan with analyst Sandeep Deshpande citing the stock's underperformance over the past three months. 5. J.M. Smucker (SJM) upgraded to Long-Term Buy on valuation at Hilliard Lyons with analyst Jeffrey Thomison citing the recent decline in shares and maintained a $140 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/09/17
WELS
08/09/17
INITIATION
Target $19
WELS
Market Perform
KeyCorp resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of KeyCorp with a Market Perform rating and $19 price target.
07/20/17
DADA
07/20/17
UPGRADE
Target $21
DADA
Buy
KeyCorp upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Kevin Reevey upgraded KeyCorp to Buy with the shares down 4% following the company's Q2 results. The analyst upped his price target for the stock to $21 from $20.
STI SunTrust
$54.64

1.07 (2.00%)

08/09/17
WELS
08/09/17
INITIATION
Target $70
WELS
Outperform
SunTrust resumed with an Outperform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of SunTrust with an Outperform rating and $70 price target.
08/03/17
MSCO
08/03/17
UPGRADE
Target $63
MSCO
Equal Weight
SunTrust upgraded to Equal Weight at Morgan Stanley
As previously reported, Morgan Stanley upgraded SunTrust to Equal Weight from Underweight with a $63 price target. Analyst Betsy Graseck expects operating leverage to be driven by consumer digitization, wholesale investments returns, and reduced branches. The analyst views risk/reward as balanced and increased FY18 estimates to reflect faster operating leverage.
08/03/17
MSCO
08/03/17
UPGRADE
MSCO
Equal Weight
SunTrust upgraded to Equal Weight from Underweight at Morgan Stanley
BBT BB&T
$44.79

0.11 (0.25%)

08/09/17
WELS
08/09/17
INITIATION
Target $44
WELS
Market Perform
BB&T resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of BB&T with a Market Perform rating and $44 price target.
07/21/17
HDLY
07/21/17
DOWNGRADE
Target $51
HDLY
Neutral
BB&T downgraded to Neutral from Long-Term Buy at Hilliard Lyons
Hilliard Lyons analyst Andrew Stapp downgraded BB&T to Neutral with a $51 price target citing valuation.
04/24/17
HDLY
04/24/17
UPGRADE
HDLY
Long-Term Buy
BB&T upgraded to Long-Term Buy from Neutral at Hilliard Lyons
08/04/17
MACQ
08/04/17
UPGRADE
Target $47
MACQ
Neutral
BB&T upgraded to Neutral from Underperform at Macquarie
Macquarie analyst David Konrad upgraded BB&T to Neutral with a $47 price target saying valuation is more reasonable following relative underperformance and operating leverage continues to improve.

TODAY'S FREE FLY STORIES

SYBX

Synlogic

$18.73

-0.52 (-2.70%)

09:40
09/19/17
09/19
09:40
09/19/17
09:40
Initiation
Synlogic initiated  »

Synlogic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

, KORS

Michael Kors

09:40
09/19/17
09/19
09:40
09/19/17
09:40
Options
Unusually active option classes on open September 19th »

Unusual total active…

KSU

Kansas City Southern

KORS

Michael Kors

AAOI

Applied Optoelectronics

$66.29

7.99 (13.71%)

RAD

Rite Aid

NKE

Nike

M

Macy's

EFX

Equifax

INTC

Intel

VIX

Volatility Index S&P 500 Options

AMD

AMD

$13.08

0.56 (4.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 23

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 28

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 16

    Nov

NKE

Nike

09:37
09/19/17
09/19
09:37
09/19/17
09:37
Recommendations
Nike analyst commentary  »

Nike risk/reward remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

SMBK

SmartFinancial

$23.88

0.38 (1.62%)

09:36
09/19/17
09/19
09:36
09/19/17
09:36
Hot Stocks
SmartFinancial, Capstone Bancshares holders approve merger-related proposals »

SmartFinancial and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
09/19/17
09/19
09:35
09/19/17
09:35
General news
FX Action: USD-CAD »

FX Action: USD-CAD edged…

PG

Procter & Gamble

09:34
09/19/17
09/19
09:34
09/19/17
09:34
Hot Stocks
Peltz says Procter & Gamble should have bought Method Soap »

Nelson Peltz of Trian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORI

Corium

$10.16

0.25 (2.52%)

, NEOS

Neos Therapeutics

$8.70

-0.5 (-5.43%)

09:33
09/19/17
09/19
09:33
09/19/17
09:33
Conference/Events
Mizuho to hold a conference »

Biotechnology CNS Deep…

CORI

Corium

$10.16

0.25 (2.52%)

NEOS

Neos Therapeutics

$8.70

-0.5 (-5.43%)

VYGR

Voyager Therapeutics

$17.36

1.01 (6.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NVAX

Novavax

$1.12

-0.02 (-1.75%)

09:32
09/19/17
09/19
09:32
09/19/17
09:32
Hot Stocks
Novavax initiates Phase 1/2 trial of NanoFlu vaccine in older adults »

Novavax announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BSMX

Santander Mexico

09:32
09/19/17
09/19
09:32
09/19/17
09:32
Downgrade
Santander Mexico rating change  »

Santander Mexico…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPLR

Xplore Technologies

$3.50

-0.2 (-5.41%)

09:31
09/19/17
09/19
09:31
09/19/17
09:31
Hot Stocks
Xplore Technologies secures Android rugged tablet order »

Xplore Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 30

    Nov

SNE

Sony

09:31
09/19/17
09/19
09:31
09/19/17
09:31
Downgrade
Sony rating change  »

Sony downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
09/19/17
09/19
09:30
09/19/17
09:30
General news
The U.S. August housing starts report »

The U.S. August housing…

BSX

Boston Scientific

09:29
09/19/17
09/19
09:29
09/19/17
09:29
Hot Stocks
Boston Scientific's HeartLogic Diagnostic shows positive risk detection ability »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBNT

Ubiquiti

$50.62

-4.335 (-7.89%)

09:28
09/19/17
09/19
09:28
09/19/17
09:28
Hot Stocks
Ubiquiti CEO to host Investor Update on September 26 »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

HQY

HealthEquity

$45.77

0.65 (1.44%)

09:26
09/19/17
09/19
09:26
09/19/17
09:26
Conference/Events
HealthEquity participates in a conference call with Chardan »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

UBNT

Ubiquiti

$50.62

-4.335 (-7.89%)

09:26
09/19/17
09/19
09:26
09/19/17
09:26
Hot Stocks
Ubiquiti Board approves additional $100M stock repurchase program »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

UBNT

Ubiquiti

$50.62

-4.335 (-7.89%)

09:23
09/19/17
09/19
09:23
09/19/17
09:23
Earnings
Ubiquiti narrows Q1 revenue view to $240M-$250M, consensus $234.5M »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

LNDC

Landec

$12.80

-0.2 (-1.54%)

09:22
09/19/17
09/19
09:22
09/19/17
09:22
Hot Stocks
Landec provides update on impact from extreme weather events »

Landec provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BOBE

Bob Evans

$72.93

1.02 (1.42%)

, POST

Post Holdings

09:19
09/19/17
09/19
09:19
09/19/17
09:19
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Bob Evans (BOBE),…

BOBE

Bob Evans

$72.93

1.02 (1.42%)

POST

Post Holdings

AZO

AutoZone

TLGT

Teligent

$6.90

-0.29 (-4.03%)

WBA

Walgreens Boots Alliance

$82.60

0.1 (0.12%)

RAD

Rite Aid

APOG

Apogee Enterprises

$44.98

0.18 (0.40%)

EFX

Equifax

ALDX

Aldeyra

$9.10

0.2 (2.25%)

SNCR

Synchronoss

$16.75

0.64 (3.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 21

    Sep

  • 22

    Sep

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

  • 30

    Oct

  • 19

    Sep

PG

Procter & Gamble

09:19
09/19/17
09/19
09:19
09/19/17
09:19
Hot Stocks
Peltz says not asking for P&G CEO David Taylor to step down »

Nelson Peltz of Trian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOX

Amdocs

$64.13

1.64 (2.62%)

09:19
09/19/17
09/19
09:19
09/19/17
09:19
Conference/Events
Amdocs participates in a conference call with Oppenheimer »

Conference call for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

09:18
09/19/17
09/19
09:18
09/19/17
09:18
Hot Stocks
Tyler Technologies selected by Odessa, Texas for ERP solution »

Tyler Technologies signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
09/19/17
09/19
09:18
09/19/17
09:18
Options
Overnight activity included 97 trades in SPX and 67 trades in VIX »

97 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

09:16
09/19/17
09/19
09:16
09/19/17
09:16
Hot Stocks
Air Products awarded oxygen supply contract by South Korean chemical company »

Air Products has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPIC

TPI Composites

$20.98

-0.05 (-0.24%)

, XYL

Xylem

09:15
09/19/17
09/19
09:15
09/19/17
09:15
Conference/Events
Cowen to hold a summit »

Industrial Innovation…

TPIC

TPI Composites

$20.98

-0.05 (-0.24%)

XYL

Xylem

WLDN

Willdan Group

$29.79

0.71 (2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 28

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.